These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29361931)

  • 21. Early clinical experience of cell-free DNA-based aneuploidy screening: A survey of obstetric sonologists in Australia and New Zealand.
    Hui L; Teoh M; Piessens S; Walker SP
    Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):138-43. PubMed ID: 25921004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal age-based prenatal screening for chromosomal disorders: attitudes of women and health care providers toward changes.
    Carroll JC; Rideout A; Wilson BJ; Allanson J; Blaine S; Esplen MJ; Farrell S; Graham GE; MacKenzie J; Meschino WS; Prakash P; Shuman C; Taylor S; Tobin S
    Can Fam Physician; 2013 Jan; 59(1):e39-47. PubMed ID: 23341678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise during pregnancy: knowledge and beliefs of medical practitioners in South Africa: a survey study.
    Watson ED; Oddie B; Constantinou D
    BMC Pregnancy Childbirth; 2015 Oct; 15():245. PubMed ID: 26446911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

  • 25. Patient-centered prenatal counseling: aligning obstetric healthcare professionals with needs of pregnant women.
    Farrell RM; Nutter B; Agatisa PK
    Women Health; 2015; 55(3):280-96. PubMed ID: 25794055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuchal translucency measurement in the era of prenatal screening for aneuploidy using cell free (cf)DNA.
    O'Brien BM; Halliday J; Lambert-Messerlian G; Eklund EE; Kloza E; Palomaki GE
    Prenat Diagn; 2017 Mar; 37(3):303-305. PubMed ID: 28124379
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of fetal gender and maternal characteristics on fetal cell-free DNA in maternal plasma.
    Zhao Q; HuoJiaBieKe J; Du S
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):653-656. PubMed ID: 31276844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstetric practice patterns in pregnancies complicated by fetal trisomy 13 or 18.
    Dotters-Katz SK; Smid MC; Mcelwain C; Kuller JA; Schulkin J
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2441-2445. PubMed ID: 28629247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
    Deruelle P; Couffignal C; Sibiude J; Vivanti AJ; Anselem O; Luton D; Benachi A; Mandelbrot L; Vauloup-Fellous C; Cordier AG; Picone O
    PLoS One; 2021; 16(9):e0256080. PubMed ID: 34516551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of noninvasive prenatal testing in obstetric care: educational resources, practice patterns, and barriers reported by a national sample of clinicians.
    Farrell RM; Agatisa PK; Mercer MB; Mitchum AG; Coleridge MB
    Prenat Diagn; 2016 Jun; 36(6):499-506. PubMed ID: 26991091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge and attitudes regarding expanded genetic carrier screening among women's healthcare providers.
    Ready K; Haque IS; Srinivasan BS; Marshall JR
    Fertil Steril; 2012 Feb; 97(2):407-13. PubMed ID: 22137493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'It's not me, it's them' - a report describing the weight-related attitudes towards obesity in pregnancy among maternal healthcare providers.
    Nagpal TS; Angrish K; Bonisteel E; Puhl RM; Ferraro ZM; Malkani NM; LeJour C; Adamo KB
    BMC Pregnancy Childbirth; 2024 Jun; 24(1):404. PubMed ID: 38831416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The personal utility of cfDNA screening: Pregnant patients' experiences with cfDNA screening and views on expanded cfDNA panels.
    Farrell RM; Agatisa PK; Michie MM; Greene A; Ford PJ
    J Genet Couns; 2020 Feb; 29(1):88-96. PubMed ID: 31680382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners.
    Menees SB; Patel DA; Dalton V
    J Womens Health (Larchmt); 2009 Aug; 18(8):1233-8. PubMed ID: 19630544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.
    Cleary-Goldman J; Morgan MA; Malone FD; Robinson JN; D'Alton ME; Schulkin J
    Obstet Gynecol; 2006 Jan; 107(1):11-7. PubMed ID: 16394034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Society for maternal-fetal medicine (SMFM) special report: the maternal-fetal medicine subspecialists' role within a health care system.
    ; Sciscione A; Berghella V; Blackwell S; Boggess K; Helfgott A; Iriye B; Keller J; Menard MK; O'Keeffe D; Riley L; Stone J
    Am J Obstet Gynecol; 2014 Dec; 211(6):607-16. PubMed ID: 25439812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between Swedish midwives' and obstetricians' & gynecologists' opinions on cesarean section.
    Josefsson A; Gunnervik C; Sydsjö A; Sydsjö G
    Matern Child Health J; 2011 Jul; 15(5):555-60. PubMed ID: 20571901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
    Shaffer BL; Norton ME
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
    Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
    J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.